During #AIDS2024, Plus life in partnership with Gilead Sciences produced a series of interviews. Here, Karl Schmid sits with Dan Murphy, Senior Director, Government Affairs & Policy, and Mercy Shibemba, HIV Activist and Advocate, to discuss the Blueprint Report and where we are in terms of ending the HIV epidemic by 2030. Continue reading THE BLUEPRINT REPORT | Dan Murphy & Mercy Shibemba
During #AIDS2024, Plus Life in partnership with Gilead Sciences produced a series of interviews. Here, Karl Schmid sits with Moupali Das, Executive Director, Clinical Development, to discuss the greatest barriers to PrEP utilization. Continue reading BARRIERS TO PrEP? | Moupali Das
During #AIDS2024, Plus Life in partnership with Gilead Sciences produced a series of interviews. Here, Karl Schmid sits with Anja Wiese, Qualified Educator, AIDS-Hilfe Krefeld e.V. to discuss the HIVISION 100 report. Continue reading HIVISION 100 REPORT | Anja Wiese
During #AIDS2024, Plus Life in partnership with Gilead Sciences produced a series of interviews. Here, Karl Schmid sits with Derek Spencer, Executive Director, Government Affairs to discuss improving initial screenings and early testing for HIV and research. Continue reading INITIAL SCREENING & TESTING | Derek Spencer
During #AIDS2024, Plus Life in partnership with Gilead sciences produced a series of interviews. Here, Karl Schmid sits with Jared Baeten, Senior Vice President, Clinical Development, Mpolokeng Mohloai, and Mitchell Warren to discuss the importance of community engagement in clinical trials Continue reading COMMUNITY ENGAGEMENT | Jared Baeten, Mpolokeng Mohloai & Mitchen Warren
During #AIDS2024, Karl Schmid sat with Ben Phillips, the Director of Communication for UNAIDS to discuss where we are at with hitting the goal of ending HIV/AIDS by 2030. Continue reading THE MESSAGE OF U=U | Konstantinos Protopapas
During #AIDS2024, Karl Schmid sat with Ben Phillips, the Director of Communication for UNAIDS to discuss where we are at with hitting the goal of ending HIV/AIDS by 2030. Continue reading THE FIGHT AGAINST HIV | Ben Phillips, UNAIDS
During #AIDS2024, Plus Life in partnership with Gilead Sciences produced a series of interviews. Here, Karl Schmid sits with Devi Sengupta, Exec. Director of Virology Therapeutic Area, to discuss why curing #HIV is so complex. Continue reading THE COMPLEXITY OF A CURE | Devi Sengupta
